Exciting news!
After months of intensive work, we are pleased to announce the launch of our latest product innovation expanding the VisionArray® product family: The VisionArray® FUNGI Chip 1.0!
After months of intensive work, we are pleased to announce the launch of our latest product innovation expanding the VisionArray® product family: The VisionArray® FUNGI Chip 1.0!
The chip enables the detection of 30 fungal pathogens of systemic mycoses at species or genus level with a single test. In addition to 6 Aspergillus and 13 Candida group species, Fusarium spp., Mucor spp. and others are also represented on the chip.
Learn more here: zytomed-systems.com, or contact your local sales representative directly to explore your testing options.
Further topics
Exciting news
Today, we are proud to announce that ZytoVision, our sister company, received the IVDR certification!
The new GATA antibody
A recently conducted study has shown that TRPS1 is expressed very highly in triple-negative breast cancer (TNBC). Expression was significantly higher than the GATA3 expression in metaplastic (85% vs. 21%) and non-metaplastic (86% vs. 51%) TNBC. Accordingly, TRPS1 has proven to be a highly specific and sensitive marker for all types of breast cancer, in particular TNBC. (Di Ai et al.; "TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer. Mod Pathol 34: 710-719, 2021)
